Bridge Research Consortium
Bridging Immune Research and Public Understanding
Together with the Bridge Research Consortium (BRC), we’re co-creating training, resources, and engaging content that help people in Canada understand the science behind immune-based innovations (e.g. vaccines and other RNA therapies)
Collaborative Content
-
Canada is stepping into the spotlight by advancing RNA medicine
mRNA is a temporary copy of the information contained in our DNA, used by cells to build proteins. Scientists are also testing new types of RNA that could help treat diseases.
-
3 things you might not know about RNA therapies
RNA therapies build on the body’s natural system to treat disease. Today, they are being explored for rare diseases, cancer, infectious diseases, and more.
-
RNA is everywhere and part of every living thing
Remember that what might seem “new” or “risky” in medicine often comes straight from the biology that’s already inside us.
Additional Resources
Invitation Community Consultation
Are you a young adult (18-34) living in or near a small city? Curious about science? Have opinions? Help the Bridge Research Consortium create a science exhibition on the immune system!
Social and behavioural insights on mRNA technology in Canada
What do people in Canada think about mRNA technologies and how do they engage with information about mRNA online?
Learn about our key findings and recommendations in BRC’s recent report
Meet the Innovators
Behind every study, dataset, and breakthrough are real people asking tough questions and testing new ideas. In this rotating spotlight, we highlight researchers and innovators who work on advancing immune science and making it accessible for everyone in Canada.
Launching Soon
About Bridge Research Consortium
The Bridge Research Consortium (BRC) is a multidisciplinary team of leading social sciences and humanities scholars, along with public health and biomedical experts, from across Canada and beyond.
The BRC is one of several projects funded as part of Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH).